Cheng, H
Liu, P
Ohlson, C
Xu, E
Symonds, L
Isabella, A
Muller, W J
Lin, N U
Krop, I E
Roberts, T M
Winer, E P
Arteaga, C L
Zhao, J J
Article History
Received: 7 March 2015
Revised: 27 August 2015
Accepted: 31 August 2015
First Online: 7 December 2015
Competing interests
: TM Roberts is a consultant of Novartis and has received research grant from Novartis. EP Winer has received research grants from Genentech and Roche. IE Krop is a consultant of Amgen and he has received research funding from Genentech. NU Lin has received research grants from Genentech, Array Biopharma, GlaxoSmithKline, Kadmon and Novartis. The other authors declare no conflict of interest.